investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Multicenter Selective Lymphadenectomy Trial (MSLT II) in Melanoma

Mark B Faries

30 Collaborator(s)

Funding source

National Cancer Institute (NIH)

No posts

Related projects

Waldemar Priebe

Targeting Resistance to BRAF Inhibitors with WP760, a Melanoma Selective Agent

Melanoma of skin

Pathology

James Q Zheng

Mechanism of growth cone turning in diffusible gradients

Melanoma of skin

Pathology

Nancy E Thomas

Melanoma RAS/BRAF Mutation: Heterogeneity-Risk-Prognosis

Melanoma of skin

Pathology

Christian Speck

DNA Replication

Melanoma of skin

Pathology

Robert White

Functional analysis of the Epstein Barr virus nuclear antigen leader protein (EBNA-LP) in a viral context.

Melanoma of skin

Pathology

Samuel Marguerat

Quantitative Gene Expression

Melanoma of skin

Pathology

Eric T Wong

The Role of Post Traumatic Stress and Substance P in Melanoma Brain Metastasis

Melanoma of skin

Pathology

Meenhard F Herlyn

The Role of Genetic Susceptibility in Melanoma Development

Melanoma of skin

Pathology

Joann G Elmore

Accuracy in the Diagnosis of Melanoma & the Impact of Double Reading

Melanoma of skin

Pathology